Details for Patent: 10,322,139
✉ Email this page to a colleague
Which drugs does patent 10,322,139 protect, and when does it expire?
Patent 10,322,139 protects ZULRESSO and is included in one NDA.
This patent has forty-five patent family members in twenty-four countries.
Summary for Patent: 10,322,139
Title: | Neuroactive steroid formulations and methods of treating CNS disorders |
Abstract: | Formulations of comprising a neuroactive steroid, e.g., allopregnanolone; and optionally a cyclodextrin, e.g., a .beta.-cyclodextrin, e.g., a sulfo butyl ether .beta.-cyclodextrin, e.g., a .beta.-cyclodextrin, e.g., a sulfo butyl ether .beta.-cyclodextrin, e.g., CAPTISOL.RTM.; and methods of use in treating CNS disorders. |
Inventor(s): | Reddy; Kiran (Boston, MA) |
Assignee: | Sage Therapeutics, Inc. (Cambridge, MA) |
Application Number: | 15/649,583 |
Patent Claim Types: see list of patent claims | Composition; Dosage form; |
Drugs Protected by US Patent 10,322,139
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sage Therap | ZULRESSO | brexanolone | SOLUTION;INTRAVENOUS | 211371-001 | Jun 17, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,322,139
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2013212287 | ⤷ Sign Up | |||
Australia | 2018201307 | ⤷ Sign Up | |||
Australia | 2020217402 | ⤷ Sign Up | |||
Brazil | 112014018110 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |